Liu, Chang-He <br/><br/>
Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats.  [electronic resource] 

 -  BMC cardiovascular disorders  12 2018 
 - 236 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2261 
<br/><br/><label>Standard No.: </label>10.1186/s12872-018-0950-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Atrial Fibrillation--enzymology<br/>Diabetes Mellitus, Experimental--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Heart Atria--drug effects<br/>Hypoglycemic Agents--pharmacology<br/>Male<br/>Metformin--pharmacology<br/>Phosphorylation<br/>Protein Kinase C--metabolism<br/>Rats, Wistar<br/>Signal Transduction--drug effects<br/>Small-Conductance Calcium-Activated Potassium Channels--metabolism